UniPharma Co., Ltd. (TPEX:6621)
Taiwan · Delayed Price · Currency is TWD 12.40
-0.15 (-1.20%)
Oct 8, 2026, 2:59 PM CST
UniPharma Market Cap
UniPharma has a market cap or net worth of 440.21 million as of October 9, 2026. It is the 39,709th most valuable company in the world and the 2,294th biggest in Taiwan. Its market cap has decreased by 0.40% in one year.
Market Cap
440.21M
Enterprise Value
344.94M
Revenue
83.87M
Global Rank
Country Rank
#2,294 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 18, 2017, UniPharma's market cap has decreased from 679.51M to 440.21M, a decrease of -35.22%. That is a compound annual growth rate of -4.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 440.21M | 2.06% |
| Dec 31, 2025 | 431.34M | -12.27% |
| Dec 31, 2024 | 491.69M | -6.42% |
| Dec 29, 2023 | 525.41M | -4.52% |
| Dec 30, 2022 | 550.27M | 37.73% |
| Dec 30, 2021 | 399.53M | -25.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.23B |
| GeneFerm Biotechnology | 1.22B |
| Anxo Pharmaceutical | 1.15B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 910.65M |
| Winston Medical Supply | 843.50M |
| Original BioMedicals | 764.95M |